
Executing an Open Innovation Model
A report by the leading consulting and research firm Deloitte noted that many biopharmaceutical companies are facing a challenging research and development environment and increased competitive pressures. Their heavy reliance on a closed, traditional model of product development might stifle true innovation and may cause biopharma companies to lag behind
Comments Off on Executing an Open Innovation Model • Read this story »